TG Therapeutics Investigational Trial Site
TG Therapeutics Investigational Trial Site
Warsaw, Poland1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis | Relapsing Multiple Sclerosis | Recruiting | Phase 2 / Phase 3 | 2026-09-21 | NCT07220252 |